Special Considerations for Running Pediatric Psychiatric Trials During Lockdown Date Published: Jun 18, 2021 Whitepaper A global pandemic makes it important to protect children, and that means taking special measures for pediatric patients in clinical trials. Signant Health’s Joan Busner discusses psychiatric studies switching to remote assessments. She elaborates on the following considerations: Safety Practical Validity/data integrity Joan also provides tips to remotely assess children during a pandemic that will help the child remain comfortable, improve comprehension in both child and caregiver, and protect the data integrity. She gives specific advice on commonly used scales and some general guidance on rating the psychiatric symptoms during COVID-19. Download Now Share: LinkedInTweet